Business Context and Reporting Period
This Form 8-K Current Report was filed by Sintx Technologies, Inc. (SINTX) on February 19, 2021, regarding events occurring on February 25, 2021. The filing discloses the entry into a Material Definitive Agreement with O2 Design, Inc. to commercialize face masks and mask filters incorporating SINTX's sintered silicon nitride technology intended to inactivate the SARS-CoV-2 virus.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a contractual agreement rather than periodic financial performance.
- Upfront Fee: O2 Design agreed to pay an upfront fee, though the specific amount is not disclosed in this text.
- Royalties: O2 Design will pay royalties on the sale of face masks and filters incorporating the silicon nitride materials.
- Milestone Payments: Potential performance-based milestone payments are included, contingent on development and sales targets.
- Payment Timing: Payment schedules for upfront fees and royalties will commence on the date a face mask incorporating the material becomes available for sale.
Material Changes and Agreement Terms
The primary material change is the execution of an exclusive worldwide Patent License Agreement with O2 Design, Inc.
- Scope: O2 Design receives an exclusive license to make, use, and sell face masks and filters using SINTX's proprietary silicon nitride.
- Supply Arrangement: SINTX will be the exclusive supplier of the sintered silicon nitride powder to O2 Design. A separate Supply Agreement is to be executed within 30 days.
- Term: The agreement expires on February 18, 2023, unless terminated earlier.
- Commercial Diligence: O2 Design must meet specific timing milestones for product development and minimum net sales to retain the exclusive license.
- Indemnification: O2 Design agreed to indemnify SINTX against claims arising from the exercise of the license or O2 Design's acts, errors, or omissions, including product liability claims resulting from gross negligence or willful misconduct.
Guidance, Risks, and Contingencies
Management commentary and risk factors are embedded within the agreement terms:
- Development Risk: There can be no assurance that a mask will be successfully developed or that any performance milestones will be met.
- Termination Rights:
- By SINTX: SINTX may terminate if O2 Design fails to make payments, violates material covenants, ceases commercial diligence efforts, or files for bankruptcy. A 90-day cure period applies for most defaults.
- By O2 Design: O2 Design may terminate the agreement at any time without cause with 120 days' written notice.
- Post-Termination: Upon expiration or termination, O2 Design may dispose of inventory for 90 days but must continue to pay royalties and render reports.
- Confidentiality: SINTX intends to claim confidential treatment for certain portions of the agreement in future filings.
Investor Verification Checklist
- Verify the specific dollar amount of the upfront fee and royalty rates, as these are not disclosed in this 8-K.
- Monitor the execution of the separate Supply Agreement, which is due within 30 days of the license agreement.
- Track the timeline for the commercial availability of the face mask to determine when revenue recognition begins.
- Review the upcoming Form 10-Q for the period ended March 30, 2021, where the full agreement is intended to be filed as an exhibit.
- Assess the risk of O2 Design terminating the agreement without cause, which could halt the commercialization of this specific product line.